Weight changes in heart failure with preserved ejection fraction: findings from TOPCAT

[1] Packer M(2018)Leptin-aldosterone-neprilysin axis: identification of its distinctive role in the pathogenesis of the three phenotypes of heart failure in people with obesity Circulation 137 1614-1631

[2] Horwich TB(2018)Obesity and the obesity paradox in heart failure Prog Cardiovasc Dis 61 151-156

[3] Fonarow GC(2019)Obesity and heart failure with preserved ejection fraction: a paradox or something else? Heart Fail Rev 24 379-385

[4] Clark AL(2019)Body mass index and all-cause mortality in heart failure patients with normal and reduced ventricular ejection fraction: a dose-response meta-analysis Clin Res Cardiol 108 119-132

[5] Tadic M(2009)Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss J Am Coll Cardiol 53 1925-1932

[6] Cuspidi C(2015)Loss in body weight is an independent prognostic factor for mortality in chronic heart failure: insights from the GISSI-HF and Val-HeFT trials Eur J Heart Fail 17 424-433

[7] Zhang J(2008)Weight loss and mortality risk in patients with chronic heart failure in the candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) programme Eur Heart J 29 2641-2650

[8] Begley A(2020)Effect of bariatric surgery on long-term cardiovascular outcomes: a nationwide nested cohort study Eur Heart J 41 2660-2667

[9] Jackson R(2019)Surgical obesity treatment and the risk of heart failure Eur Heart J 40 2131-2138

[10] Harrison M(2018)Bariatric surgery among patients with heart failure: a systematic review and meta-analysis Open Heart 5 131-137

[1] Packer M(2018)Leptin-aldosterone-neprilysin axis: identification of its distinctive role in the pathogenesis of the three phenotypes of heart failure in people with obesity Circulation 137 1614-1631

[2] Horwich TB(2018)Obesity and the obesity paradox in heart failure Prog Cardiovasc Dis 61 151-156

[3] Fonarow GC(2019)Obesity and heart failure with preserved ejection fraction: a paradox or something else? Heart Fail Rev 24 379-385

[4] Clark AL(2019)Body mass index and all-cause mortality in heart failure patients with normal and reduced ventricular ejection fraction: a dose-response meta-analysis Clin Res Cardiol 108 119-132

[5] Tadic M(2009)Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss J Am Coll Cardiol 53 1925-1932

[6] Cuspidi C(2015)Loss in body weight is an independent prognostic factor for mortality in chronic heart failure: insights from the GISSI-HF and Val-HeFT trials Eur J Heart Fail 17 424-433

[7] Zhang J(2008)Weight loss and mortality risk in patients with chronic heart failure in the candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) programme Eur Heart J 29 2641-2650

[8] Begley A(2020)Effect of bariatric surgery on long-term cardiovascular outcomes: a nationwide nested cohort study Eur Heart J 41 2660-2667

[9] Jackson R(2019)Surgical obesity treatment and the risk of heart failure Eur Heart J 40 2131-2138

[10] Harrison M(2018)Bariatric surgery among patients with heart failure: a systematic review and meta-analysis Open Heart 5 131-137